Alcoholic liver disease (ALD) is a major public health problem worldwide and is the leading cause of end-stage liver disease. While the ultimate control of ALD will require the prevention of alcohol abuse, better understanding of the mechanisms of alcohol-induced liver injury may lead to treatments of fatty liver, alcoholic hepatitis, and prevention or delay of occurrence of cirrhosis. The elucidation and the discovery of several new concepts in ALD pathogenesis have raised our understanding on the complex mechanisms and the potential in developing the new strategies for therapeutic benefits. In this review, we provide the most up-to-date information on the basic molecular mechanisms focusing on the role of fat-specific protein 27/CIDEC in the pathogenesis of ALD.
SozioMS, LiangpunsakulS, CrabbD. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Semin Liver Dis2010;30:378–90. doi:10.1055/s-0030-1267538
2.
GaoB, BatallerR. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology2011;141:1572–85. doi:10.1053/j.gastro.2011.09.002
KondiliLA, TalianiG, CergaG, . Correlation of alcohol consumption with liver histological features in non-cirrhotic patients. Eur J Gastroenterol Hepatol2005;17:155–9. doi:10.1097/00042737-200502000-00005
5.
BadalooA, ReidM, SoaresD, . Relation between liver fat content and the rate of VLDL apolipoprotein B-100 synthesis in children with protein-energy malnutrition. Am J Clin Nutr2005;81:1126–32.
6.
HuangJ, IqbalJ, SahaPK, . Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology2007;46:147–57. doi:10.1002/hep.21632
7.
XuMJ, CaiY, WangH, . Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. Gastroenterology2015;149:1030–41.e6. doi:10.1053/j.gastro.2015.06.009
8.
LiangL, ZhaoM, XuZ, . Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family. Biochem J2003;370:195–203. doi:10.1042/BJ20020656
9.
MatsusueK, KusakabeT, NoguchiT, . Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab2008;7:302–11. doi:10.1016/j.cmet.2008.03.003
XuX, ParkJG, SoJS, . Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis. Hepatology2015;61:857–69. doi:10.1002/hep.27371
13.
KellerP, PetrieJT, De RoseP, . Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem2008;283:14355–65. doi:10.1074/jbc.M708323200
14.
GreenbergAS, ColemanRA, KraemerFB, . The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest2011;121:2102–10. doi:10.1172/JCI46069
15.
UenoM, ShenWJ, PatelS, . Fat-specific protein 27 modulates nuclear factor of activated T cells 5 and the cellular response to stress. J Lipid Res2013;54:734–43. doi:10.1194/jlr.M033365
16.
PuriV, KondaS, RanjitS, . Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J Biol Chem2007;282:34213–18. doi:10.1074/jbc.M707404200
17.
GrahnTH, KaurR, YinJ, . Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes. J Biol Chem2014;289:12029–39. doi:10.1074/jbc.M113.539890
18.
SinghM, KaurR, LeeMJ, . Fat-specific protein 27 inhibits lipolysis by facilitating the inhibitory effect of transcription factor Egr1 on transcription of adipose triglyceride lipase. J Biol Chem2014;289:14481–7. doi:10.1074/jbc.C114.563080
19.
RobenekH, RobenekMJ, TroyerD. PAT family proteins pervade lipid droplet cores. J Lipid Res2005;46:1331–8. doi:10.1194/jlr.M400323-JLR200
20.
DaneschU, HoeckW, RingoldGM. Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression. J Biol Chem1992;267:7185–93.
21.
WilliamsPM, ChangDJ, DaneschU, . CCAAT/enhancer binding protein expression is rapidly extinguished in TA1 adipocyte cells treated with tumor necrosis factor. Mol Endocrinol1992;6:1135–41. doi:10.1210/mend.6.7.1508226
22.
YuS, MatsusueK, KashireddyP, . Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem2003;278:498–505. doi:10.1074/jbc.M210062200
23.
PuriV, RanjitS, KondaS, . Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci USA2008;105:7833–8. doi:10.1073/pnas.0802063105
24.
BaysH, MandarinoL, DeFronzoRA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab2004;89:463–78. doi:10.1210/jc.2003-030723
25.
BodenG. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes1997;46:3–10. doi:10.2337/diab.46.1.3
26.
Vilà-BrauA, De Sousa-CoelhoAL, GonçalvesJF, . Fsp27/CIDEC is a CREB target gene induced during early fasting in liver and regulated by FA oxidation rate. J Lipid Res2013;54:592–601. doi:10.1194/jlr.M028472
27.
AibaraD, MatsusueK, MatsuoK, . Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver. Biol Pharm Bull2013;36:1766–72. doi:10.1248/bpb.b13-00351
28.
BertolaA, MathewsS, KiSH, . Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc2013;8:627–37. doi:10.1038/nprot.2013.032
29.
NaveauS, DobrinAS, BalianA, . Body fat distribution and risk factors for fibrosis in patients with alcoholic liver disease. Alcohol Clin Exp Res2013;37:332–8. doi:10.1111/j.1530-0277.2012.01927.x
30.
HartCL, MorrisonDS, BattyGD, . Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ2010;340:c1240. doi:10.1136/bmj.c1240
31.
XuJ, LaiKK, VerlinskyA, . Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol2011;55:673–82. doi:10.1016/j.jhep.2010.12.034
32.
ChangB, XuMJ, ZhouZ, . Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1. Hepatology2015;62:1070–85. doi:10.1002/hep.27921
LanghiC, BaldánÁ. CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor alpha and plays a critical role in fasting- and diet-induced hepatosteatosis. Hepatology2015;61:1227–38. doi:10.1002/hep.27607
